| Quarterly Financials | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 33 | 30 | 93 | 60 | 33 | 122 | 49 | 50 | 43 | 27 | 39 | 30 | 23 | 24 | 35 | 28 | 16 | 26 | 34 | 28 | 34 | 37 |
| Expenses | 29 | 17 | 56 | 52 | 28 | 72 | 41 | 43 | 44 | 31 | 42 | 29 | 25 | 24 | 30 | 27 | 21 | 23 | 34 | 31 | 31 | 35 |
| EBITDA | 4 | 13 | 37 | 9 | 6 | 49 | 8 | 7 | -1 | -5 | -3 | 1 | -1 | -0 | 5 | 2 | -6 | 3 | 1 | -3 | 3 | 2 |
| Operating Profit % | 11 % | 43 % | 39 % | 13 % | 14 % | 39 % | 13 % | 11 % | -7 % | -22 % | -13 % | -3 % | -16 % | -14 % | 4 % | -19 % | -26 % | -12 % | -8 % | -15 % | 4 % | -2 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Profit Before Tax | 3 | 13 | 36 | 9 | 5 | 49 | 8 | 6 | -2 | -5 | -4 | 0 | -2 | -1 | 4 | 1 | -7 | 3 | -0 | -3 | 2 | 1 |
| Tax | 1 | 3 | 9 | 2 | 1 | 13 | 2 | 2 | -1 | -1 | -1 | 0 | -0 | -0 | 1 | 1 | -2 | 1 | 0 | -1 | -0 | 0 |
| Net Profit | 2 | 9 | 27 | 6 | 4 | 36 | 5 | 5 | -1 | -4 | -3 | 0 | -2 | -1 | 3 | 0 | -4 | 2 | -1 | -3 | 3 | 1 |
| EPS in ₹ | 3.40 | 13.50 | 38.19 | 8.53 | 4.56 | 36.20 | 5.43 | 4.73 | -1.40 | -4.13 | -2.89 | 0.30 | -1.53 | -0.71 | 2.90 | 0.16 | -4.15 | 1.66 | -0.48 | -2.80 | 2.47 | 0.81 |
Nureca
Nureca
230.78
+0.30
(0.13%)
Market Cap
230.50 Cr
EPS
0.85
PE Ratio
-
Dividend Yield
0.00 %
Industry
Healthcare52 Week High
447.50
52 Week Low
203.62
PB Ratio
1.18
Debt to Equity
0.02
Sector
Medical Equipment
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Company News
View All News
Nureca Limited has filed a scheme for merger by absorption of its wholly owned subsidiary, Nureca Technologies Private Limited. The Board of Directors approved the draft merger scheme on May 20, 2025, subject to statutory and regulatory approvals. Nureca Limited reported revenue of Rs 1,146.40 crores and net-worth of Rs 1,917.38 crores for the year ended March 31, 2025, while Nureca Technologies recorded revenue of Rs 228.14 crores and net-worth of Rs 53.94 crores. The merger aims to improve operational efficiency, eliminate inter-corporate dependencies, minimize administrative compliances, and maximize shareholder value through reduced overheads and simplified group structure. No shares will be issued as part of the scheme, and there will be no change in shareholding pattern. The company has also approved the strike-off of another wholly owned subsidiary, Nureca Healthcare Private Limited, which is non-material and non-functional.
Nureca Reports Strong Q4 Growth and Expands DistributionMay 05, 2025
Nureca has reported an 87% growth for Q4 FY25. The company is expanding its reach by partnering with Swiggy for distribution. Additionally, Nureca has outlined its strategic priorities for the upcoming fiscal year FY26.
Nureca Expands Quick Commerce Reach via Swiggy InstamartApr 29, 2025
Nureca has expanded its quick commerce reach by making Dr Trust products available on Swiggy Instamart. This move allows Nureca to tap into Swiggy's extensive delivery network, potentially increasing the accessibility and sales of Dr Trust products through a popular quick commerce platform.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,951.00 | #1 19,739.30 | 55.30 | #1 1,759.00 | 22.62 | #1 339 | 25.81 | 44.32 | |
327.75 | 1,787.40 | 77.90 | 242.40 | 24.12 | 25 | -50.60 | 42.58 | |
309.00 | 1,623.60 | 59.59 | 408.40 | 32.64 | 30 | -55.00 | 29.32 | |
605.00 | 1,017.30 | 61.67 | 249.37 | 40.00 | 17 | -20.59 | 47.36 | |
596.00 | 957.90 | 47.95 | 186.60 | 40.62 | 20 | - | 53.31 | |
547.00 | 651.80 | 34.75 | 67.10 | 13.15 | 18 | 18.92 | 41.96 | |
274.95 | 518.80 | #1 32.50 | 136.30 | #1 107.77 | 16 | - | 60.73 | |
318.75 | 326.30 | 42.05 | 111.80 | -1.43 | 8 | -0.10 | 48.51 | |
287.00 | 304.80 | 37.71 | 89.85 | 0.60 | 7 | #1 752.54 | 55.44 | |
230.78 | #10 230.50 | - | #7 122.10 | #7 19.24 | #10 1 | #8 -52.94 | 36.02 |
Forecast
Actual
Growth Rate
Revenue Growth
19.24 %
Net Income Growth
-144.44 %
Cash Flow Change
-604.06 %
ROE
-147.31 %
ROCE
-222.86 %
EBITDA Margin (Avg.)
1,236.67 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 24 | 34 | 186 | 219 | 207 | 205 | 210 |
| Fixed Assets | 1 | 1 | 4 | 10 | 9 | 7 | 9 |
| Current Assets | 23 | 33 | 181 | 206 | 187 | 193 | 190 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 33 | 59 | 94 | 1 |
| Other Assets | 23 | 33 | 182 | 175 | 139 | 104 | 200 |
| Total Liabilities | 24 | 34 | 186 | 219 | 207 | 205 | 210 |
| Current Liabilities | 15 | 10 | 19 | 12 | 9 | 9 | 12 |
| Non Current Liabilities | 0 | 9 | 4 | 4 | 3 | 3 | 3 |
| Total Equity | 8 | 15 | 163 | 203 | 195 | 193 | 194 |
| Reserve & Surplus | 8 | 15 | 153 | 193 | 185 | 183 | 184 |
| Share Capital | 0 | 0 | 10 | 10 | 10 | 10 | 10 |
Cash Flow
| Cash Flow | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 0 | 17 | -9 | -8 | 14 | -11 |
| Investing Activities | -0 | -0 | -110 | -3 | -17 | 18 | 8 |
| Operating Activities | 0 | -8 | 35 | 1 | 10 | -3 | -19 |
| Financing Activities | -0 | 8 | 92 | -7 | -2 | -1 | -0 |
Share Holding
| % Holding | Jan 2020 | Feb 2021 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 93.33 % | 70.00 % | 70.00 % | 70.00 % | 70.00 % | 70.00 % | 70.00 % | 70.00 % | 70.00 % | 62.98 % | 62.98 % | 62.98 % | 63.24 % | 63.24 % | 63.24 % | 63.24 % | 63.77 % | 64.06 % | 64.30 % | 64.33 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.10 % | 0.00 % | 0.08 % | 0.08 % | 0.69 % | 0.36 % | 1.07 % | 0.08 % |
| DIIs | 0.00 % | 3.54 % | 5.71 % | 5.40 % | 5.42 % | 5.43 % | 5.23 % | 5.23 % | 0.58 % | 0.03 % | 0.02 % | 0.02 % | 0.02 % | 0.00 % | 0.02 % | 0.04 % | 0.04 % | 0.04 % | 0.04 % | 0.04 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 5.87 % | 4.49 % | 4.32 % | 5.50 % | 5.18 % | 8.49 % | 8.54 % | 25.85 % | 34.17 % | 34.06 % | 34.24 % | 34.32 % | 33.61 % | 33.73 % | 34.24 % | 32.97 % | 33.27 % | 32.39 % | 33.12 % |
| Others | 6.67 % | 20.59 % | 19.80 % | 20.28 % | 19.07 % | 19.40 % | 16.29 % | 16.23 % | 3.57 % | 2.82 % | 2.94 % | 2.76 % | 2.33 % | 3.16 % | 2.94 % | 2.41 % | 2.53 % | 2.27 % | 2.20 % | 2.45 % |
| No of Share Holders | 19 | 8,436 | 7,827 | 10,060 | 12,618 | 15,471 | 26,123 | 26,114 | 63,911 | 62,007 | 58,560 | 55,569 | 52,255 | 49,600 | 45,996 | 43,813 | 41,986 | 41,314 | 39,304 | 38,075 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2 | 3 | 0.00 | 0.00 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.15 | 1 | 0.00 | 0.00 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 23 Sept 2021 |  Dividend | ₹ 2.00 /share | 21 Sept 2021 | 1,549.00 | 1,634.10 |
| 25 Feb 2022 | Dividend | ₹ 3.00 /share | 24 Feb 2022 | 1,591.15 | 1,300.35 |
| 18 Jul 2024 |  Annual General Meeting | NA | 18 Jul 2024 | 277.90 | 275.50 |
| 24 Oct 2024 |  Quarterly Result Announcement | NA | 24 Oct 2024 | 299.65 | 299.35 |
| 24 Jan 2025 | Quarterly Result Announcement | NA | 24 Jan 2025 | 389.15 | 360.70 |
| 05 May 2025 | Quarterly Result Announcement | NA | 05 May 2025 | 248.00 | 228.80 |
| 16 Jun 2025 | Annual General Meeting | NA | 16 Jun 2025 | 228.80 | 279.00 |
| 15 Jul 2025 | Quarterly Result Announcement | NA | 15 Jul 2025 | 285.40 | 288.80 |
Announcements
Closure of Trading Window
2 days ago
2 days agoFiling Of Scheme Under Regulation 37(6) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)Jul 24, 2025
Jul 24, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 16, 2025
Jul 16, 2025Announcement under Regulation 30 (LODR)-Investor PresentationJul 15, 2025
Jul 15, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 15, 2025
Jul 15, 2025Board Meeting Outcome for Nureca Limited Has Informed The Exchange Regarding Unaudited Financial Results For The Quarter Ended 30Th June2025.Jul 15, 2025
Jul 15, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 15, 2025
Jul 15, 2025Board Meeting Intimation for Declaration Of Unaudited Standalone/Consolidated Financial Results For The Quarter Ended June 302025 Alongwith Other Business Matters .Jul 09, 2025
Jul 09, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJul 08, 2025
Jul 08, 2025Closure of Trading WindowJun 28, 2025
Jun 28, 2025Closure of Trading WindowJun 28, 2025
Jun 28, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportJun 17, 2025
Jun 17, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportJun 17, 2025
Jun 17, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMJun 16, 2025
Jun 16, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2025
May 27, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2025
May 27, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 24, 2025
May 24, 2025Notice Of Annual General Meeting To Be Held On 16Th June2025May 23, 2025
May 23, 2025Annual ReportMay 23, 2025
May 23, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 22, 2025
May 22, 2025Announcement Under Regulation 30May 20, 2025
May 20, 2025Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations
And Disclosure Requirements) Regulations 2015May 20, 2025
May 20, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 07, 2025
May 07, 2025Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sMay 06, 2025
May 06, 2025Announcement under Regulation 30 (LODR)-Resignation of DirectorMay 06, 2025
May 06, 2025Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sMay 06, 2025
May 06, 2025Announcement under Regulation 30 (LODR)-CessationMay 06, 2025
May 06, 2025Book ClosureMay 05, 2025
May 05, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 05, 2025
May 05, 2025Announcement under Regulation 30 (LODR)-Investor PresentationMay 05, 2025
May 05, 2025Board Meeting Outcome for OUTCOME OF BOARD MEETING HELD ON 05 MAY 2025May 05, 2025
May 05, 2025Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 30, 2025
Apr 30, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 29, 2025
Apr 29, 2025Business UpdateApr 29, 2025
Apr 29, 2025Board Meeting Intimation for Consider And Approve Inter-Alia The Audited Financial Results
(Standalone And Consolidated) Along With Other Business Matters For The Fourth Quarter And Full Year Ended On March 31 2025.Apr 28, 2025
Apr 28, 2025Nureca Limited Has Informed The Exchange Regarding Business Update .Apr 21, 2025
Apr 21, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 15, 2025
Apr 15, 2025Business UpdateApr 15, 2025
Apr 15, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 12, 2025
Apr 12, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportApr 01, 2025
Apr 01, 2025Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015.Mar 31, 2025
Mar 31, 2025Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading )Regulations 2015Mar 31, 2025
Mar 31, 2025Closure of Trading WindowMar 31, 2025
Mar 31, 2025Nureca Limited Has Informed The Exchange Regarding Nureca Limited Has Informed The Exchange Regarding Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015Mar 28, 2025
Mar 28, 2025Nureca Limited Has Informed The Exchange Regarding Revised Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015Mar 17, 2025
Mar 17, 2025Nureca Limited Has Informed The Exchange Regarding Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015Mar 15, 2025
Mar 15, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 28, 2025
Feb 28, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 24, 2025
Feb 24, 2025Outcome Of Board Meeting Under Regulation 30 Of SEBI (LODR)Regulations2015Feb 24, 2025
Feb 24, 2025Nureca Limited Has Informed The Exchange Regarding Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations2015.
Feb 14, 2025
Feb 14, 2025Technical Indicators
RSI(14)
Neutral 36.02
ATR(14)
Less Volatile 8.95
STOCH(9,6)
Oversold 5.67
STOCH RSI(14)
Oversold 3.44
MACD(12,26)
Bearish -2.76
ADX(14)
Weak Trend 22.05
UO(9)
Bullish 23.06
ROC(12)
Downtrend And Accelerating -10.97
WillR(14)
Oversold -91.45
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
